Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
Epstein-Barr Virus-Associated Primary Vitreoretinal B-Cell Lymphoma in a Patient Receiving Tofacitinib and
Catherine Qin1, Youssef Helmy1,2, Marta Latasiewicz1
1Ophthalmology Department, Stoke Mandeville Hospital, Buckinghamshire Healthcare NHS Foundation Trust, Aylesbury, UK.
Purpose:
To describe a rare case of Epstein-Barr virus (EBV)-associated primary vitreoretinal B-cell lymphoma in a patient receiving tofacitinib and methotrexate for psoriatic arthritis, highlighting the diagnostic challenges and clinical implications of iatrogenic immunosuppression.
Methods:
A 42-year-old man on combined tofacitinib and methotrexate therapy presented with recurrent vitritis refractory to corticosteroid treatment. Diagnostic investigations included aqueous and vitreous polymerase chain reaction (PCR) testing for viral DNA, flow cytometry for lymphoid clonality, and systemic imaging to exclude extraocular disease.
Results:
PCR testing confirmed the presence of EBV DNA in both aqueous and vitreous samples, while flow cytometry demonstrated a monoclonal B-cell population consistent with lymphoma. Systemic evaluation revealed no evidence of extraocular involvement. Following diagnostic pars plana vitrectomy, intraocular inflammation resolved without the need for chemotherapy, and the patient remains disease-free under close surveillance.
Conclusion:
EBV-associated primary vitreoretinal lymphoma may arise in the context of combined methotrexate and JAK inhibitor therapy. This case highlights the importance of considering masquerade syndromes in steroid-refractory uveitis, incorporating EBV PCR testing into diagnostic workup, and recognizing the potential role of immunosuppression in ocular lymphomagenesis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

